BeiGene
Price & Volume
Stats
See more52W Range | $141.31-$287.88 |
Market Cap | $30.5B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $4.1B |
Revenue Growth (YoY) | 48.6% |
Gross Profit (12 Mos) | $3.5B |
Diluted EPS | -$3.65 |
News
See moreYahoo Finance • 5 days ago
Nurix Therapeutics' SWOT analysis: promising BTK degrader stock faces challenges
Yahoo Finance • 7 days ago
BeOne gets FDA nod for tablet version of zanubrutinib
Yahoo Finance • 7 days ago
U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications
Yahoo Finance • 17 days ago
We Did The Math FTHI Can Go To $24
About
CEO | Mr. John V. Oyler |
Address | Aeschengraben 27, Basel, Switzerland, 4051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11,000 |
